share_log
Benzinga ·  Apr 25 12:16
Eyenovia Shares Are Trading Higher After the Company Announced Clinical and Scientific Updates on Its FDA-approved Products Mydcombi and Clobetasol Propionate Ophthalmic Suspension
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment